xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R]
Usd: 185 Special Discount
Specification
Safety datasheet
Overview
Product Name
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R]
Antibody Type
Recombinant Mouse Monoclonal Antibody
Immunogen
293 cell line overexpressing SLC7A11.
Species Reactivity
Human, Mouse
Validated Applications
WB, IHC-P, IF-Cell, FC
Molecular Weight
Predicted band size: 55 kDa
Positive Control
HT-29 cell lysate, A549 cell lysate, HCT116 cell lysates, human pancreas tissue, HT-29, NIH/3T3 cell lysates.
Conjugation
unconjugated
Clone Number
A7C6-R
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:500-1:5,000
-
IHC-P
-
1:200
-
IF-Cell
-
1:100-1:200
-
FC
-
1:1,000
Target
Function
This gene encodes a member of a heteromeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate. In this system, designated Xc(-), the anionic form of cysteine is transported in exchange for glutamate. This protein has been identified as the predominant mediator of Kaposi sarcoma-associated herpesvirus fusion and entry permissiveness into cells. Also, increased expression of this gene in primary gliomas (compared to normal brain tissue) was associated with increased glutamate secretion via the XCT channels, resulting in neuronal cell death.
Background References
1. Koppula P. et. al. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021 Aug
2. Lin W. et. al. SLC7A11/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020 Oct
Subcellular Location
Cell membrane, Cell projection, microvillus membrane.
Synonyms
Amino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
ExpandAmino acid transport system xc xCT antibody antibody
Amino acid transport system xc- antibody
Calcium channel blocker resistance protein CCBR1 antibody
Calcium channel blocker resistance protein CCBR1 antibody antibody
CCBR1 antibody
Cysteine/glutamate transporter antibody antibody
Cystine/glutamate transporter antibody
OTTHUMP00000164578 antibody
SLC7A11 antibody
Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 antibody
solute carrier family 7 antibody
Solute carrier family 7 member 11 antibody
Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 antibody
SYSTEM Xc(-) TRANSPORTER-RELATED PROTEIN antibody
xCT antibody
XCT_HUMAN antibody
CollapseImages
-
Western blot analysis of xCT / SLC7A11 on different lysates with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/500 dilution.
Lane 1: HT-29 cell lysate
Lane 2: A549 cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Exposure time: 30 seconds;
10% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601071) at 1/500 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1:100,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of xCT / SLC7A11 on HCT116 cell lysates with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/5,000 dilution.
Lysates/proteins at 10 µg/Lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Exposure time: 1 minute;
12% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601071) at 1/5,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1:100,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human pancreas tissue with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601071) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of HT-29 cells labeling xCT / SLC7A11 with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HT-29 cells labeling xCT / SLC7A11.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA601071, 1/1,000) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for 30 minutes, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Western blot analysis of xCT / SLC7A11 on NIH/3T3 cell lysates with Mouse anti-xCT / SLC7A11 antibody (HA601071) at 1/500 dilution.
Lysates/proteins at 10 µg/Lane.
Predicted band size: 55 kDa
Observed band size: 55 kDa
Exposure time: 1 minute;
8% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA601071) at 1/500 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1:150,000 dilution was used for 1 hour at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Ultrasound and ROS-responsive nanodroplets inhibit TCA cycle in hepatocellular carcinoma
Journal: Journal Of Nanobiotechnology
DOI: 10.1186/s12951-026-04190-y
IF: 12.6
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 Mar
-
Ginsenoside Rg1 attenuates PM2.5-induced neurotoxicity by suppressing ferroptosis via the Nrf2/GPx4 axis
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2026.121464
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Functional characterization of triokinase/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2026.151597
IF: 8.5
Application: WB
Reactivity: Human,Mouse
Publish date: 2026 Mar
-
Manganese Biomineralized Ferritin Nanoplatforms with Shielding and Stimuli-Responsive Release for Potentiated Ferroptosis and Multimodal Ovarian Cancer Therapy
Journal: International Journal Of Nanomedicine
DOI: 10.2147/IJN.S548411
IF: 6.5
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Jan
-
NOX2 exacerbates periodontitis via JAK2-STAT3-mediated ferroptosis of gingival epithelial cells
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2026.1744612
IF: 5.9
Application: WB
Reactivity: Human,Mouse
Publish date: 2026 Feb
-
Proanthocyanidin B2 Alleviates Cuprizone-Induced Demyelination by Regulating the Astrocytic xCT/GSH/GPX4 Axis
Journal: CNS Neuroscience & Therapeutics
DOI: 10.1111/cns.70598
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Synergistic ferroptosis-immunotherapy nanoassembly via PROTAC-mediated SLC7A11 degradation and trisulfide-driven glutathione depletion for enhanced antitumor efficacy
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2025.168827
IF: 13.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Unveiling Novel Biomarkers: Ferroptosis and m1A in the Progression of Nanographene-Induced Lung Fibrosis
Journal: Small
DOI: 10.1002/smll.202508818
IF: 12.1
Application: IHC,WB
Reactivity: Mouse
Publish date: 2025 Nov
-
Targeting inducible nitric oxide synthase with 1400W mitigates septic acute lung injury through inhibiting SLC7A11/GPX4 mediated ferroptosis
Journal: Nitric Oxide - Biology and Chemistry
DOI: 10.1016/j.niox.2025.05.008
IF: 3.2
Application: IHC
Reactivity: Mouse
Publish date: 2025 May
-
Swietenine improved the progression of diabetic nephropathy through inhibiting ferroptosis via activating Akt/GSK-3β/Nrf2 signaling pathway
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.119981
IF: 4.8
Application: WB
Reactivity: Rat,Mouse
Publish date: 2025 May
-
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
Journal: Frontiers In Oncology
DOI: 10.3389/fonc.2025.1580828
IF: 3.5
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 May
-
SLC7A11, a disulfidptosis-related gene, correlates with multi-omics prognostic analysis in hepatocellular carcinoma
Journal: European Journal of Medical Research
DOI: 10.1186/s40001-025-02411-y
IF: 2.8
Application: IHC-P
Reactivity: Human
Publish date: 2025 Mar
-
5‐HT7R Deficiency Alleviates ADP‐Heptose‐Induced Cognitive Impairment via Inhibiting Ferroptosis and Neuroinflammation in Mice
Journal: CNS Neuroscience & Therapeutics
DOI: 10.1111/cns.70455
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
Synergizing Ferroptosis and Immunotherapy via a PROTAC/PDT/HPK1 Inhibitor-Loaded Nanoplatform for Enhanced Antitumor Efficacy
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202507906
IF: 19
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Translational medicine research on the role of key gene network modulation mediated by procyanidin B2 in the precise diagnosis and treatment of multiple sclerosis
Journal: Journal Of Translational Medicine
DOI: 10.1186/s12967-025-06741-7
IF: 7.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Silymarin ameliorates diet-induced gallstone formation by regulating gut microbiota-derived GCDCA to suppress ferroptosis-ROS-NFκB signaling pathway
Journal: Free Radical Biology And Medicine
DOI: 10.1016/j.freeradbiomed.2025.08.003
IF: 8.2
Application: IHC,WB
Reactivity: Mouse
Publish date: 2025 Aug
-
Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway
Journal: Phytomedicine
DOI:
IF: 6.7
Application: WB
Reactivity: Rat
Publish date: 2024 Sep
-
Ferroptosis Exists in Ischemia Reperfusion Injury after Cardiac Surgery with Cardiopulmonary Bypass
Journal: Cell Biochemistry And Biophysics
DOI:
IF: 2.6
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
Paeoniflorin suppresses ferroptosis after traumatic brain injury by antagonizing P53 acetylation
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2024.155940
IF: 6.7
Application: WB
Reactivity: Mouse
Publish date: 2024 Aug
-
Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization
Journal: Aggregate
DOI:
IF: 18.8
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
Icariin inhibits chondrocyte ferroptosis and alleviates osteoarthritis by enhancing the SLC7A11/GPX4 signaling
Journal: International Immunopharmacology
DOI:
IF: 5.6
Application: WB
Reactivity: Human,Rat
Publish date: 2024 Apr
-
Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity
Journal: European Journal Of Pharmacology
DOI:
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2022 Jul
Products with the same target and pathway
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C6]
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [PSH19-94]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [PSH19-94] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Mouse Monoclonal Antibody [A7C6-R] - BSA and Azide free
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Mouse Monoclonal Antibody [A7C5]
Application: WB,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
xCT / SLC7A11 Recombinant Rabbit Monoclonal Antibody [JE31-93]
Application: WB,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated